1217628-46-0

Basic information

• Product Name: piperazine-1,3(R)-dicarboxylic acid-1-(9H-fluoren-9-ylmethyl) ester
• Synonyms: piperazine-1,3(R)-dicarboxylic acid-1-(9H-fluoren-9-ylmethyl) ester
• CAS NO: 1217628-46-0
• Molecular Weight: 352.39
• Mol File: 1217628-46-0.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: piperazine-1,3(R)-dicarboxylic acid-1-(9H-fluoren-9-ylmethyl) ester(CAS DataBase Reference)
• NIST Chemistry Reference: piperazine-1,3(R)-dicarboxylic acid-1-(9H-fluoren-9-ylmethyl) ester(1217628-46-0)
• EPA Substance Registry System: piperazine-1,3(R)-dicarboxylic acid-1-(9H-fluoren-9-ylmethyl) ester(1217628-46-0)

Safety Data

• Hazardous Substances Data: 1217628-46-0(Hazardous Substances Data)

Upstream product

• 218278-58-1 (2S)-1-tert-butoxycarbonyl-4-(9H-fluoren-9-ylmethoxycarbonyl)piperazine-2-carboxylic acid 
• 159532-59-9 (2S)-1-{[(1,1-dimethylethyl)oxy]carbonyl}-2-piperazinecarboxylic acid 
• 28920-43-6 (fluorenylmethoxy)carbonyl chloride 

Relevant articles and documents

CERAMIDE GALACTOSYLTRANSFERASE INHIBITORS FOR THE TREATMENT OF DISEASE

Described herein are compounds, methods of making such compounds, pharmaceutical compositions and medicaments containing such compounds, and methods of using such compounds to treat or prevent diseases or disorders associated with the enzyme ceramide galactosyltransferase (CGT), such as, for example, lysosomal storage diseases. Examples of lysosomal storage diseases include, for example, Krabbe disease and Metachromatic Leukodystrophy.